Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
Elizabeth A. Thompson, Katherine Cascino, Alvaro A. Ordoñez, et al.
Cell Reports (2021) Vol. 34, Iss. 11, pp. 108863-108863
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Monocytes and Macrophages in COVID-19
Rainer Knoll, Joachim L. Schultze, Jonas Schulte-Schrepping
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 235
Metabolic adaptation of lymphocytes in immunity and disease
Nicole M. Chapman, Hongbo Chi
Immunity (2022) Vol. 55, Iss. 1, pp. 14-30
Open Access | Times Cited: 174
Antibodies to combat viral infections: development strategies and progress
Giuseppe Pantaleo, Bruno E. Correia, Craig Fenwick, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 676-696
Open Access | Times Cited: 138
Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19
Fotios Karagiannis, Konrad Peukert, Laura Surace, et al.
Nature (2022) Vol. 609, Iss. 7928, pp. 801-807
Open Access | Times Cited: 109
Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study
Світлана Зубченко, Iryna Kril, Олена Надіжко, et al.
Rheumatology International (2022) Vol. 42, Iss. 9, pp. 1523-1530
Open Access | Times Cited: 103
T Cell Metabolism in Infection
Jonas Aakre Wik, Bjørn S. Skålhegg
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 91
Metabolic programs tailor T cell immunity in viral infection, cancer, and aging
Sofie Hedlund Møller, Pei‐Chun Hsueh, Yi-Ru Yu, et al.
Cell Metabolism (2022) Vol. 34, Iss. 3, pp. 378-395
Open Access | Times Cited: 75
Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice
Alvaro A. Ordoñez, C. Korin Bullen, A.F. Villabona-Rueda, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 69
Durable SARS-CoV-2 B cell immunity after mild or severe disease
Clinton O. Ogega, Nicole Skinner, Paul W. Blair, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 7
Open Access | Times Cited: 94
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning
Shannon R. McCurdy, Vedran Radojčić, Hua‐Ling Tsai, et al.
Blood (2021) Vol. 139, Iss. 4, pp. 608-623
Open Access | Times Cited: 63
Pathogenesis of Respiratory Viral and Fungal Coinfections
Fabián Salazar, Elaine Bignell, Gordon D. Brown, et al.
Clinical Microbiology Reviews (2021) Vol. 35, Iss. 1
Open Access | Times Cited: 59
Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
Annamaria Paolini, Rebecca Borella, Sara De Biasi, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1585-1585
Open Access | Times Cited: 54
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
Ankit Verma, Anna Shteinfer‐Kuzmine, Nikita Kamenetsky, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 52
Hematopoietic responses to SARS-CoV-2 infection
Shokrollah Elahi
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 51
SARS-CoV-2: A Master of Immune Evasion
Alberto Rubio‐Casillas, Elrashdy M. Redwan, Vladimir N. Uversky
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1339-1339
Open Access | Times Cited: 50
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models
Yisheng Jiang, Yong‐Qiang Deng, Huanhuan Pang, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 37
SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
Stephen L. Archer, Asish Dasgupta, Kuang‐Hueih Chen, et al.
Redox Biology (2022) Vol. 58, pp. 102508-102508
Open Access | Times Cited: 37
Apoptotic proteins with non-apoptotic activity: expression and function in cancer
Varda Shoshan‐Barmatz, Tasleem Arif, Anna Shteinfer‐Kuzmine
APOPTOSIS (2023) Vol. 28, Iss. 5-6, pp. 730-753
Open Access | Times Cited: 32
Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine
Haoqiang Lai, Ligeng Xu, Chang Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 21
SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19
Joseph W. Guarnieri, Jeffrey Haltom, Yentli E. Soto Albrecht, et al.
Pharmacological Research (2024) Vol. 204, pp. 107170-107170
Open Access | Times Cited: 8
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets
Rittibet Yapasert, Patompong Khaw-on, Ratana Banjerdpongchai
Molecules (2021) Vol. 26, Iss. 24, pp. 7459-7459
Open Access | Times Cited: 49
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
Ivan Zanoni
Current Opinion in Virology (2021) Vol. 50, pp. 119-127
Open Access | Times Cited: 41
Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease
Hernán F. Peñaloza, Janet Lee, Prabir Ray
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009850-e1009850
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top